Life evolved in an aqueous environment, necessitating the evolution of carrier proteins to shuttle lipophilic molecules within and between cells. Sandhu et. al. (2018) report the discovery of a long-sought-after cholesterol carrier protein, named Aster, which transports cholesterol from the plasma membrane to the endoplasmic reticulum.
Lipid membranes are essential for cellular life as we know it, enabling the subdivision of the cellular space into membraneencapsulated organelles with specialized functions. This innovation of nature, however, presents significant challenges. Transport of lipophilic molecules between membrane compartments must overcome the intervening aqueous environment, requiring specialized carrier proteins. One of the most important transported molecules is cholesterol, a key structural component of lipid membranes and also the precursor for steroid hormones and bile acids in steroidogenic organs and liver, respectively (Ikonen, 2008) . Uptake of cholesterol in these tissues occurs primarily from high-and low-density lipoproteins (HDL and LDL, respectively) via cell-surface receptors, such as scavenger receptor class B member I (SR-BI) and LDL receptor, respectively (Krieger, 2001) . How cholesterol is transported throughout the cell after this step, particularly from the plasma membrane to the endoplasmic reticulum (ER) where it is sensed by the SREBP-SCAP-INSIG protein complex and used for steroid hormone synthesis (Brown et al., 2018) , has been a longstanding question. In this issue of Cell, Sandhu et al. solve this mystery with their discovery of the ER-resident proteins Aster-A, -B, and -C that contain unique domains for binding cholesterol and the plasma membrane, thereby serving as a molecular bridge for the transfer of cholesterol from the plasma membrane to the ER (Sandhu et al., 2018) (Figure 1 ).
Studies of liver X receptors (LXRs) and their regulation of sterol homeostasis in Peter Tontonoz's lab led to the discovery of the gene Gramd1b as a direct target of LXRa/b ( Figure 1 ). Gramd1b, along with related genes Gramd1a and Gramd1c, are highly conserved in vertebrates but had no known function. Modeling reveals that the central ASTER (Greek for ''star'') domain of the resulting proteins (named Aster-A, -B, and -C) display remarkable similarity to the sterol-binding START domain. Indeed, binding assays demonstrate that the ASTER domain has an affinity for cholesterol rivaling that of the canonical START-domain protein StARD1. Furthermore, the ASTER domain transports cholesterol more efficiently between membranes in vitro than the START domain. The crystal structure of the ASTER domain in complex with cholesterol, while partially resembling the START domain, reveals a striking juxtaposition of non-polar and basic residues at the tip of the ASTER domain that hint at a potential interaction with phospholipids.
The binding assays and structural analysis suggested that the Asters could be involved in transporting cholesterol between membranes-but which membranes? To answer this question, the authors express the Asters as GFP-fusion proteins in cells and track their subcellular localization. In standard lipid-poor conditions, the Asters are located throughout the ER. Upon addition of cholesterol to the media, the Asters quickly redistribute to ER tubules abutting the plasma membrane. This remarkable movement indicates that the Asters possess an affinity for a component of the plasma membrane. The authors hypothesized that the N-terminal GRAM domain, a domain type that was previously shown to bind phospholipids (Begley et al., 2003) , may be responsible for recruiting Asters to the phospholipid-rich plasma membrane. Consistent with this prediction, the isolated Aster GRAM domain binds to phosphatidylserine-containing liposomes and redistributes to the plasma membrane in a cholesterol-dependent manner.
The authors then set out to determine the functional importance of the Aster proteins in cholesterol trafficking and homeostasis. Global deletion of Aster-B in mice leads to a profound loss of cholesterol esters in the adrenal gland, demonstrating the requirement of Aster-B for cholesterol homeostasis in vivo. In cultured 3T3-L1 adipocytes, loss of the highest expressed Aster-A activates the SREBP-2 pathway, which normally occurs in response to cholesterol deficiency in the ER to upregulate genes involved in cholesterol uptake and synthesis (Brown et al., 2018) (Figure 1 ). Furthermore, suppression of SREBP-2 activation by exogenous cholesterol and the production of cholesterol esters are both delayed in Aster-A-deficient cells. Finally, the authors show that Aster-B-deficient adrenal glands are cholesterol starved, as reflected by increased SREBP-2 activation, and fail to produce normal levels of corticosterone.
Balance between the activities of two families of sterol responsive transcription factors, the SREBPs and LXRs, is necessary for maintenance of cholesterol homeostasis. While the SREBPs regulate uptake and synthesis of cholesterol and fatty acids in cells (Brown et al., 2018) , the oxysterol-responsive LXRs regulate genes involved in cholesterol storage, export, and degradation (Wang and Tontonoz, 2018) . The discovery of the Aster proteins by Sandhu and colleagues not only answers a basic question about cholesterol trafficking but also reveals a new connection between these two sterol responsive pathways. For example, as cholesterol accumulates in the cytosol, cholesterol-derived oxysterols activate LXRs, resulting in induction of Aster-B to enhance transfer of cholesterol from the plasma membrane to the ER (Figure 1) . The net increase in ER cholesterol is then sensed by the SREBP2-SCAP-INSIG protein complex, resulting in retention of SREBP-2 in the ER and a decrease in expression of genes involved in cholesterol uptake and synthesis. Taken together with previous studies, which have Binding of HDL to SR-B1 on the cell surface results in transfer of cholesterol to the plasma membrane and cytosol. Asters are integral membrane proteins in the ER that facilitate transport of lipoprotein-derived cholesterol from the plasma membrane to the ER. The gene Gramd1b (encoding Aster-B) is upregulated by LXRs, which are activated by cholesterol-derived oxysterols. In the ER, cholesterol suppresses SREBP-2, a transcription factor that promotes cholesterol synthesis, thereby establishing a negative feedback loop for maintaining cholesterol homeostasis.
shown that LXR transcriptionally regulates expression of the lipogenic transcription factor SREBP-1c in the liver (Repa et al., 2000) , the current findings illustrate how dynamic crosstalk between these two sterol responsive transcription factors fine tunes cholesterol metabolism in cells.
The discovery of the Aster proteins and their role in cholesterol trafficking raises additional questions. First, the tissue-specific expression patterns of the three Aster proteins suggest that they have non-redundant roles in cholesterol trafficking and metabolism, which will need to be investigated using tissue-specific knockout mice. Second, because the ER also makes contacts with other membranous organelles, such as the mitochondria, endosomes, and lysosomes, it will be important to investigate whether Asters are also involved in inter-organelle cholesterol trafficking. Third, the selective binding of phosphatidylserine by the GRAM domain of Aster-B has important immunological implications. For instance, cell death is accompanied by rapid externalization of phosphatidylserine, which is normally restricted to the inner leaflet of plasma membranes (Poon et al., 2014) . In macrophages, a cell type with high expression of Aster-B (Sandhu et al., 2018) , the ER provides the additional membrane for phagocytosis (Gagnon et al., 2002) , raising the possibility that the recruitment of Aster-B to the plasma membrane might facilitate recognition and phagocytosis of apoptotic cells. If so, genetic deficiency of Aster-B in macrophages would be expected to impair clearance of apoptotic cells, resulting in development of autoimmunity, a phenotype observed in LXRdeficient animals (A-Gonzalez et al., 2009) . Fourth, in addition to its requirement for corticosteroid synthesis, Aster-B might be important for the synthesis of sex hormones and, by extension, many aspects of sexual development and dimorphism. And finally, functions of Asters will need to be investigated in diseases associated with alterations in cholesterol metabolism, including dyslipidemia, atherosclerosis, diabetes, chronic inflammation, and neurodegeneration. Addressing these and other questions ensures a bright future for Asters.
